Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Why Relay Therapeutics Is Up 30% This Week
October 15, 2021
Tickers
RHHBY
RLAY
Tags
Market News
RLAY
RHHBY
From
Motley Fool
2 Penny Stocks That Could Soar Soon
October 14, 2021
Tickers
AZN
BGNE
LPTX
PIRS
Tags
LPTX
AZN
BGNE
From
Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
Tickers
ABBV
BMY
GILD
JNJ
Tags
Biotech
Partner Content
General
From
Benzinga
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
October 14, 2021
Tickers
AZN
RHHBY
Tags
RHHBY
Market News
AZN
From
Motley Fool
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
October 14, 2021
Tickers
CBIO
CRSP
FBIO
IPOS
Tags
Guidance
Small Cap
Penny Stocks
From
Benzinga
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
October 13, 2021
Tickers
AMRS
DNA
RHHBY
TGT
Tags
AMRS
RHHBY
Market News
From
Motley Fool
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
Tickers
AVIR
DOCS
FB
ILMN
Tags
NVAX
Market News
MSFT
From
Motley Fool
Sarepta's Duchenne Gene Therapy Shows Sustained Functional Improvements
October 11, 2021
Tickers
RHHBY
SRPT
Tags
Briefs
Health Care
News
From
Benzinga
4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill
October 11, 2021
Tickers
AVIR
MRK
PFE
RHHBY
Tags
MRK
Market News
PFE
From
Motley Fool
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
October 08, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
FDA Breakthrough Designation
FDA
RHHBF
From
Benzinga
Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?
October 08, 2021
Tickers
AVIR
MRK
MRNA
NVAX
Tags
PFE
RHHBY
Market News
From
Motley Fool
Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst
October 06, 2021
Tickers
BNTX
JNJ
MRK
MRNA
Tags
RHHBY
PFE
BofA Securities
From
Benzinga
Moderna Is Down 12%. Is It Time to Buy?
October 06, 2021
Tickers
MRK
MRNA
RHHBY
Tags
Market News
MRK
RHHBY
From
Motley Fool
Why Novavax Stock Plunged in September
October 06, 2021
Tickers
AVIR
BNTX
MRNA
NVAX
Tags
RHHBY
PFE
Market News
From
Motley Fool
Which COVID-19 Pill Stock Is the Best Buy?
October 05, 2021
Tickers
AVIR
BNTX
MRK
PFE
Tags
PFE
RHHBY
AVIR
From
Motley Fool
2 Best Biotech Stocks to Buy In October
October 04, 2021
Tickers
AVIR
IBB
MRK
OCGN
Tags
AVIR
XBI
OCGN
From
Motley Fool
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
Tickers
AVIR
MRK
MRNA
NVAX
Tags
PFE
RHHBY
REGN
From
Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
Tickers
AVIR
MRK
PFE
RDHL
Tags
MRK
Market News
RDHL
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Tickers
ANIP
AVDL
BHC
CALT
Tags
BHC
EYEN
GILD
From
Benzinga
Labcorp's At Home Collection Kit Gets EUA Nod For Combined COVID-19 and Flu Detection
October 01, 2021
Tickers
LH
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Benzinga
Market News
From
Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
October 01, 2021
Tickers
BNTX
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Market News
Benzinga
From
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Tickers
ABBV
ADMA
AGTC
AIM
Tags
XLRN
GLPG
News
From
Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
September 30, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Phase 3 Trial
RHHBF
RHHBY
From
Benzinga
3 COVID Stocks Ready to Take On the Delta Variant
September 27, 2021
Tickers
BNTX
GILD
LLY
NVAX
Tags
GILD
Market News
NVAX
From
Motley Fool
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
Tickers
GSK
REGN
RHHBF
RHHBY
Tags
Health Care
News
REGN
From
Benzinga
3 Biotech Stocks That Could Make You Filthy Rich
September 27, 2021
Tickers
ADAP
AMGN
AZN
CHGCY
Tags
NVAX
Market News
AMGN
From
Motley Fool
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
Tickers
AMGN
BMY
GILD
MRK
Tags
M&A
GILD
MRK
From
Benzinga
September Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
September 25, 2021
Tickers
CRSP
NDAQ
RHHBY
VRTX
Tags
RHHBY
VRTX
NDAQ
From
Motley Fool
Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients
September 24, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
News
Health Care
From
Benzinga
WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
September 24, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
RHHVF
From
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today